Cascader completed a seed financing round led by Topcon Healthcare to advance its first ophthalmic AI products toward market launch and expand its team The company's initial focus is on macular ...
At 6 months, third-generation Z+ IOL eyes achieved mean uncorrected visual acuity of 20/24 at distance and 20/26 at near under photopic conditions No serious adverse events or halos were reported; 79% ...
The first patients have been dosed in the global phase 3 ORBIT clinical trial of linsitinib, an oral small molecule inhibitor of the insulin-like growth factor-1 receptor for the treatment of adults ...
Zeiss Medical Technology expanded its retinal imaging portfolio with Zeiss Alta Duo 300, a fully automated, compact, multimodal imaging solution. 1 The device offers a fully automated structural OCT ...
World Sight Day 2026 will be observed Oct. 8, with Prevent Blindness and its partners offering vision screenings, educational resources and other eye health activities A new pediatric optometry ...
Research found virtual reality (VR) to be a promising tool for educating patients and improving their level of satisfaction during IOL selection for cataract surgery More patients in the VR versus ...
Get breaking ophthalmic news, device and drug updates, clinical trial coverage, thought-leader perspective, and industry announcements.
Zeiss AT Lucia Toric 721P IOL and DORC EVA Nexus Cataract Configuration ...
Research presented at the 44th Congress of the ESCRS found that a simple preoperative test using a phoropter could accurately predict the success of laser blended vision surgery This form of LASIK for ...
Key Takeaways The AT LUCIA Toric 721P (Carl Zeiss Meditec) is a bitoric hydrophobic monofocal IOL with a nonconstant asphericity profile design.
B+L Advances Two Ophthalmic Pipeline Therapies in DED and Ocular Surface Pain ...
B+L Advances Two Ophthalmic Pipeline Therapies in DED and Ocular Surface Pain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results